rs587777023
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_004588.5(SCN2B):c.632A>G(p.Asp211Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000149 in 1,613,902 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004588.5 missense
Scores
Clinical Significance
Conservation
Publications
- atrial fibrillation, familial, 14Inheritance: AD, Unknown Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Genomics England PanelApp
- familial atrial fibrillationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152108Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251438 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461794Hom.: 0 Cov.: 31 AF XY: 0.0000165 AC XY: 12AN XY: 727198 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Variant of unknown significance Uncertain:1
- -
Atrial fibrillation, familial, 14 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 211 of the SCN2B protein (p.Asp211Gly). This variant is present in population databases (rs587777023, gnomAD 0.002%). This missense change has been observed in individual(s) with Brugada syndrome (PMID: 23559163). ClinVar contains an entry for this variant (Variation ID: 60776). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects SCN2B function (PMID: 23559163, 28597987). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
- -
Cardiovascular phenotype Uncertain:1
The p.D211G variant (also known as c.632A>G), located in coding exon 4 of the SCN2B gene, results from an A to G substitution at nucleotide position 632. The aspartic acid at codon 211 is replaced by glycine, an amino acid with similar properties. This alteration was reported in a subject with Brugada syndrome, but was also seen in family members with nonspecific symptoms or who were unaffected (Riuró H et al. Hum. Mutat., 2013 Jul;34:961-6). This alteration may have an impact in protein function (Riuró H et al. Hum. Mutat., 2013 Jul;34:961-6; Dulsat G et al. Biol. Cell, 2017 Jul;109:273-291). This amino acid position is not well conserved in available vertebrate species, and glycine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at